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phosphoramidites in oligonucleotide synthesis affords an 
automatable codon-level mutagenesis method 
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and Xavier Sober6n2 
Background: Synthetic DNA has been used to introduce variability into 
protein-coding regions. In protocols that produce a few mutations per gene, the 
sampling of amino-acid sequence space is limited by the bias imposed by the 
genetic code. It has long been apparent that the incorporation of trinucleotides 
in the synthetic regime would circumvent this problem and significantly enhance 
the usefulness of the technique. 
Results: A new method is described for the creation of codon-level degenerate 
oligodeoxyribonucleotides that combines conventional dimethoxytrityl (DMT) 
mononucleoside phosphoramidite chemistry with 9-fluorenylmethoxycarbonyl 
(Fmoc) trinucleotide phosphoramidites (whose synthesis is reported in the 
paper). The substoichiometric use of these Fmoc-trinucleotides in an 
automatable, solid-phase synthesis procedure afforded DNA fragments 
comprising the wild-type sequence and a controllable distribution of mutants 
within two- and three-codon stretches of DNA, within the multiple cloning site of 
the conventional cloning vector pUCl9. 
Conclusions: DMT and Fmoc are compatible protecting groups in 
conventional oligonucleotide synthesis methods, resulting in controllable levels 
of codon-based mutagenesis. 
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Introduction 
It has been recognized for a number of years that muta- 
genesis methods aimed at creating diversity in gene frag- 
ments of various sizes suffer from important drawbacks: a 
bias introduced by the genetic code and inherent limita- 
tions in the distribution of replacements that result from 
the substitution of bases one by one, as opposed to three 
at a time [l]. These limitations are particularly relevant 
when the goal is to achieve one or a few mutations per 
gene (nonsaturating conditions) as opposed to saturating 
conditions concentrated in one or a few contiguous 
codons [‘2,3]. For example, directed evolution methods 
frequently require uniform generation of diversity over 
whole genes [4,5], but a mutant collection averaging one 
amino-acid replacement per gene will only sample about 
25% of all possible replacements with currently available 
methods [3]. Alanine-scanning mutagenesis, which is 
performed by introducing alanine replacements one by 
one [6], would similarly benefit from the creation of 
libraries containing a high representation of one alanine 
replacement per gene. 
A number of strategies have been used to improve the 
performance of nonsaturating mutagenesis methods 
[3,7,8], with synthetic DNA offering, in principle, the 
best starting point to achieve the most sophisticated 
mutagenesis schemes. Degenerate oligonucleotides (col- 
lections of synthetic DNA fragments that vary in one or 
more positions) have been used as mutagenic agents for 
more than a decade [9], and synthetic DNA offers an 
obvious approach to drastically enhance the diversity gen- 
erated: whole mutagenic oligonucleotides (oligos) could 
be synthesized using trinucleotides, thereby easily con- 
trolling the proportion of degenerate codons by varying 
the molar ratio of wild-type codon trinucleotides with 
respect to a mixture of up to 20 other trinucleotides, 
coding for the rest of the amino acids [&lo-121. It should 
be noted, however, that most of the work described so far 
has been performed using DMT-trinucleotides at saturat- 
ing conditions, with Shortle and Sondek [lo] reporting 
substoichiometric coupling, for insertions only, combin- 
ing DMT-mononucleotides and DMT-trinucleotides. A 
major disadvantage of using exclusively trinucleotides is 
the difficulty of maintaining the stock of trinucleotides 
and the correspondingly high increased cost. Employing 
only monomers, the introduction of a eontrolled propor- 
tion of wild-type versus degenerate codons has also been 
achieved using the splitting-column method [13,14,8], 
which requires the interruption of the oligonucleotide 
synthesis and the separation of the solid support into two 
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parts (in different proportions, if wanted); one part is sub- 
jected to three mononucleotide couplings with the wild- 
type sequence, whereas the other is subjected to three 
consecutive nucleotide couplings with appropriate mix- 
tures of mononucleotides. The two portions of the resin 
are re-mixed and the cycle repeated as needed. Here, the 
main drawback is that frequent separation and re-mixing 
of the resin is tedious, hard to automate and deleterious 
to the overall yield. 
Shortle and Sondek proposed in 1992 [lo] a scheme that 
could potentially achieve the controlled doping of oligos 
in a codon-oriented manner via substoichiometric cou- 
pling of trinucleotide phosphoramidites (Figure 1). No 
experimental results, however, have appeared so far using 
the proposed approach, which involved the use of alterna- 
tive chemistries at the 5’ protecting group. We report here 
the experimental implementation of such a method, and 
demonstrate that 9-fluorenylmethoxycarbonyl (Fmoc) and 
dimethoxytrityl (DMT) are protecting groups compatible 
with each other and with the conventional phospho- 
ramidite-synthesis protocols, thereby permitting fully 
automated synthesis of mutagenic oligos with codon- 
based variability. 
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Chemical synthesis of Fmoc-TTT-phosphoramidite 5. Synthon 4 was 
assembled using the phosphotriester method as described in the 
Materials and methods section. DCA, dichloroacetic acid; DCM, 
dichloromethane; NMI, N-methylimidazole; DIPEA, 
N,N-diisopropylethylamine. 
Results and discussion (Dnseoc) [16], Z-(2,4-dinitrobenzenesulphenyloxymethyl) 
Selection of protecting groups and synthesis of Fmoc- benzoyl (DNBSB) [17], 9-fluorenylmethoxycarbonyl 
trinucleotide-phosphoramidites (Fmoc) [18-201, t-butyldimethylsilyl (TBDMS) [Zl], 
Out of several alternative 5’ hydroxyl protecting groups t-butyldiphenylsilyl (TBDPS) [ZZ]), we chose Fmoc for 
(e.g., levulinyl (Lev) [ 15 1, Z-dansylethoxycarbonyl use in further experiments, because of its commercial 
522 Chemistry & Biology Vol 5,No 9 
Pro Arg 
(a) 5’tga att cga get m tat m ggg ate ctc3’ 
Eco RI Barn HI 
(b) 5’cc gga att cga gcatacaggg ate ctc eta gc3’ 
(c) 5’gct agg agg ate c 3’ 
get 
Cd) 5’tag gag gat ccc cg/ 
get get 
xx : 
tcg aat tea ctc gga c3’ 
gta ccg age 
Figure 3 
The oligonucleotides synthesized in this study. 
(a) Wild-type sequence coding for the j3- 
galactosidase a-fragment. A change in the 
proline codon destroys the Sac1 restriction 
site, whereas a change in the arginine codon 
destroys the Smal restriction site. 
(b) Oligonucleotide libraries (LMRL or HMRL) 
were created using different proportions of 
DMT-dGib-phosphoramidite to Fmoc-TTT- 
phosphoramidite. (c) The first extension 
primer (EPl). (d) Oligonucleotide libraries 
(LM-AS or HM-AS) for alanine scanning 
were created using dilute solutions of Fmoc- 
GCT-phosphoramidite. (e) The second 
extension primer (EP2). 
(e) 5’gtc cga gtg aat tcg3’ 
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availability, proven performance in biopolymer synthesis 
[l&19], stability, regio-selectivity [ZO] and rapid removal 
in mild basic conditions. Synthon 4, precursor of the 
Fmoc-TTT-phosphoramidite 5, was synthesized as 
shown in Figure 2 using the phosphotriester method in 
solution phase, through a fully protected scheme that 
made use of 3’-0-DMT-thymidine 1 and 5’-O-Fmoc- 
thymidine 2. Intermediate compounds were purified by 
flash column chromatography and their structure and 
purity was spectroscopically verified (see the Materials 
and methods section). Phosphitylation of 4 with the 
monophosphitylating reagent N,N-diisopropyl-methyl- 
phosphonamidic chloride afforded the target compound 
5, which was only semi-purified by rapid flash chromatog- 
raphy in the presence of 10% pyridine in dichloro- 
methane. Upon n-hexane precipitation, we obtained a 
white powder that was stable, when stored dry at -20°C 
for at least 2 years. In acetonitrile and standard tempera- 
ture, the compound had a half-life of 6.7 days (as mea- 
sured by high performance liquid chromatography 
(HPLC) [23]), which is ample time to conduct automated 
oligonucleotide synthesis. 
To carry out a preliminary assessment of the suitability of 
levulinyl as protecting group, we synthesized S’-O-Fmoc-Z- 
N-isobutyryldeoxyguanosine-3’-O-methyl-N,N-diisopropyl- 
phosphoramidite and 5’-O-Lev-Z-N-isobutyryldeoxy- 
guanosine-3’-O-methyl-N,N-diisopropylphosphoramidite. 
Preliminary results indicate that levulinyl derivatives are 
indeed more stable in solution than those containing Fmoc. 
At 10 mM concentration in acetonitrile, Fmoc- and Lev- 
containing compounds had half-lives of 6.5 and 20.1 days, 
respectively. These results suggest that the levulinyl group 
could have advantages for the protection of the trimers. We 
confirmed, however, that one problem associated with 
levulinyl nucleosides is the low regioselectivity of the 
levulinyl group towards the 5’ hydroxyl group at the 
moment of nucleoside protection, yielding a high quantity 
of the 3’ byproduct [24], whose elimination by column 
chromatography was difficult. 
In order to demonstrate the feasibility of the synthetic 
route shown in Figure 2 for the preparation of other 
Fmoc-trinucleotides, we also synthesized the Fmoc- 
GCT-phosphoramidite, which corresponds to an alanine 
codon, useful in the alanine-scanning mutagenesis proce- 
dure [6]. In this case, during the preparation of the Fmoc- 
GC dimer, significant amounts of byproduct were 
generated (evident by thin layer chromatography (TLC) 
analysis) after acidic hydrolysis of the 3’-DMT protecting 
group, as a direct consequence of the depurination of N- 
isobutyryl-deoxyguanosine to acid. After column purifica- 
tion, the dimer could be obtained in a pure form, but only 
at a 17% overall yield. To solve the problem, we decided 
to use N-benzoyl-deoxycytidine instead of 3’-O-DMT-N- 
benzoyl-deoxycytidine for the internucleotidic coupling, 
even at the expense of possible 3’-3’ coupling. After 
column purification, the 5’-3’ Fmoc-GC dimer was 
obtained in a pure form with a 62% overall yield. The 
authenticity of this compound was confirmed using 
HPLC, after removal of all protecting groups and direct 
comparison with a GC dimer prepared by solid-phase 
automated synthesis (see the Supplementary material). 
The Fmoc-GC dimer was then similarly reacted with 
unprotected thymidine to obtain the Fmoc-GCT trimer, 
precursor of the Fmoc-GCT-phosphoramidite, which was 
subsequently column-purified. 
Design and synthesis of mutagenic oligonucleotides 
We used the Fmoc-TTT-phosphoramidite to test the com- 
patibility with DMT-based chemistry, employing the 
oligonucleotide synthesis protocol shown in Figure 1 
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Restriction analysis of representative library clones, (a) Wild-type 
sequence, (b) double mutant, (c) single mutant in Sac1 site, (d) single 
mutant in Smal site. Lanes 1, plasmid without digestion, lanes 2, Smal 
digestion; lanes 3, Sac1 digestion; M, molecular weight marker. 
(detailed in the Materials and methods section). As a model 
study, we decided to introduce a certain proportion of the 
TTT codon at two positions within the wild-type sequence 
of the poly-linker segment of the gene encoding the a- 
peptide of P-galactosidase in a conventional cloning vector 
(see Figure 3). A DNA cassette derived from these oligos 
could be cloned as an EcoRI-BarnHI fragment and the sub- 
stitution of the arginine and proline codons by TTT would 
destroy a SmaI or a Sac1 restriction site, respectively. In 
order to demonstrate the controllability of the mutagenesis 
rate and the distribution of mutants, we synthesized two 
oligonucleotide libraries, at high mutagenic rates (HMRL) 
and low mutagenic rates (LMRL) (1:1.36 and 1:7.9 trimer 
to monomer molar ratio, respectively). As both codons have 
guanine at the third position, the procedure required the 
preparation of only two mixtures of the DMT-G monomer 
with the Fmoc-TTT phosphoramidites, one for each of the 
two different molar ratios. The incorporation of monomers 
during the synthesis was monitored spectrophotometri- 
tally; the incorporation of Fmoc-containing synthons was 
inferred by subtraction, with an average yield of 28.6% for 
HMRL and 8.1% for LMRL. 
Table 1 
The Fmoc-GCT-phosphoramidite was employed to scan 
three contiguous amino acids (valine, proline and serine) 
located between the EcoRI and BarnHI sites of the poly- 
linker region described above, as shown in Figure 3d 
(coding strand complementary to that shown in 
Figure 3a). Again, we synthesized two alanine-scanning 
libraries at different mutagenesis rates, employing the 
protocol described by Shortle and Sondek [lo] instead of 
preparing mixtures of monomers and trimers. In this case, 
we used only diluted solutions of the trimer, coupling 
them at the beginning of the codons to be scanned, and 
skipping the capping step. The library at high mutagene- 
sis rate (HM-AS) was prepared with the Fmoc-trimer at 
31.1 mM concentration in acetonitrile, whereas the library 
at low mutagenesis rate (LM-AS) was prepared at an 
Fmoc-trimer concentration of 16.7 mM. 
Cloning of duplex DNA fragments and distribution analysis 
Purified DNA cassettes were obtained with DNA poly- 
merase and extension primer 1 (EPl) using the HMRL or 
LMRL oligos as template. The cassettes were cloned into 
plasmid pUC19 as EcoRI-BarnHI restriction fragments. 
For each mutagenesis rate we analyzed 40 clones by 
restriction enzyme digesting with SnzaI and SacI; the 
observed rate of disappearance of the restriction site was 
taken as indication of replacement by the mutagenic trin- 
ucleotide TTT (Figure 4 and Table 1). Sequencing of 
selected clones (one for each category and mutagenesis 
rate) confirmed that all of them contained only the 
expected changes. The small sample analyzed is reason- 
ably consistent with the distribution of replacements 
expected theoretically. 
Similarly, the DNA cassettes for alanine scanning were 
created using the HM-AS and LM-AS oligonucleotides 
with extension primer 2 (EPZ). In this case, we analyzed 50 
clones for each mutagenesis rate by sequencing the DNA 
directly. With LM-AS, we obtained 42 wild-type clones, 
seven single mutants and one double mutant, whereas in 
the case of HM-AS we obtained 36 wild-type, 11 single 
- 
Sacl/Smal restriction analysis of individual clones of the oligonucleotide libraries at low (LMRL) and high (HMRL) mutagenesis rate. 
LMRL HMRL 
Clone phenotype 
Wild type 
Double mutants 
Sacl single mutant 
Smal single mutant 
Total single mutants 
Number of Experimental Theoretical 
clones fraction (O/o) fraction (O/o) 
36 90.0 84.4 
1 2.5 0.6 
1 2.5 7.4 
2 5.0 7.4 
3 7.5 14.8 
Number of Experimental Theoretical 
clones fraction (O/o) fraction (o/o) 
20 50.0 50.9 
6 15.0 8.2 
4 10.0 20.4 
10 25.0 20.4 
14 35.0 40.8 
The theoretical fraction was calculated using the binomial distribution equation. Forty clones were analyzed in total in each case (LMRL 
and HMRL). 
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mutants and three double mutants. Again, the results 
broadly correlate with the expected mutagenesis rate. 
Significance 
Our results demonstrate that it is possible to combine two 
different 5’ protecting groups in an automated oligonu- 
cleotide synthesis protocol and obtain enzymatically and 
biologically active molecules. The combination of 9-fluo- 
renylmethoxycarbonyl (Fmoc)-trinucleotides and 
dimethoxytrityl (DMT)-mononucleotides allowed us to 
manipulate the introduction of sequence substitutions at 
the codon level, resulting in a controlled distribution of 
single and multiple amino-acid replacements in the coded 
protein. The general application of this, or related proto- 
cols, should provide for a new mutagenesis method, with 
significant advantages over pre-existing ones. 
Materials and methods 
‘H and 31P nuclear magnetic resonance (NMR) analyses were 
obtained at 300 and 121 MHz on a Varian VXR. The samples were 
tested on a mixture of CDCI,-DMSO containing tetramethylsilane as 
internal reference or 85% HsPO, as external reference, respectively. 
Fast atom bombardment-mass spectrometry (FAB-MS) analyses were 
obtained on a Jeol JSM-SX 102A with double beam using m-nitroben- 
zylalcohol as matrix. Melting points (mp) were determined on a Fisher- 
Johns melting point apparatus and are reported uncorrected. All 
reactions were followed using TLC on aluminum-backed silica gel 60 
F 2s4 sheets (Merck) using CHCI,/MeOH (9:l v/v) as the elution 
system. The products were purified by flash column chromatography 
using silica gel 60H (Merck, 5-40 pm) as the stationary phase and 
methanol gradients in CH,CI, for the elution process. The reagents 
employed for synthesis of the Fmoc-trinucleotide-phosphoramidites 
were all purchased from Aldrich and used without additional treat- 
ments. The mutagenic oligonucleotides were assembled on an Applied 
Biosystems DNA Synthesizer 381 A using a 0.2 mmol standard proto- 
col as recommended by the manufacturer. Oligonucleotide libraries 
were created through a combination of DMT-nucleoside-Me-phospho- 
ramidites (Glen Research) and the Fmoc-trinucleotide-phospho- 
ramidites synthesized in this work. All additional reagents for 
oligonucleotide synthesis were prepared from Aldrich. Reagents for 
electrophoresis including acrylamide, agarose and buffers were all pur- 
chased from Sigma or Bio-Rad. Restriction endonucleases, T4 DNA 
ligase, Klenow polymerase, pUCl9 plasmid and dNTP’s were bought 
from Boheringer Mannheim and used according to standard protocols. 
Syntheses 
3’~O-($4’.dimethoqMyl)thymidine (1). 5’-O-t-butyldimethylsilylthymi- 
dine (3.56 g, 10 mmol), prepared as described by Sproat et a/. [221, was 
co-evaporated with pyridine (2 x 30 ml) and re-dissolved in 60 ml of the 
same solvent. 4,4’-0-dimethoxytrityl chloride (DMT-Cl, 4.61 g, 
13.6 mmol) was added in powder under nitrogen and the reaction was 
kept overnight under magnetic stirring. On the following day, when the 
reaction was shown to be almost complete using TLC analysis, the 
excess of DMT-Cl was quenched with methanol for 30min and the 
mixture was concentrated to dryness. The oily residue was taken up in 
dichloromethatie and washed with saturated sodium bicarbonate and 
brine. After drying and filtering from anhydrous sodium sulfate, the 
organic phase was concentrated to an oil and subjected to flash column 
chromatography to quickly remove the 4,4’-0-dimethoxytritylmethyl ether 
byproduct. The semi-purified intermediate 5’-0-t-butyldimethylsilyl-3’-O- 
(4,4’-0-dimethoxytrityl)thymidine, obtained as a foam, was dissolved in 
100 ml of THF and treated with 1.2 equivalents of tetrabutylammonium 
fluoride overnight to remove the TBDMS group. The reaction work-up 
was as before and the product was carefully purified by flash chromatog- 
raphy using a gradient of ethyl acetate (AcOEt) in n-hexane. The product 
was eluted with 90% of AcOEt and was finally obtained as a white 
powder (3.55 g) by precipitation from cold n-hexane. 
Overall yield 65.3%; R, 0.74; mp 127-128°C; ‘H NMR (CDCI,): 6 
9.13 (H3, lH, s), 7.44-6.83 (aromatics, 14H, m), 6.15 (Hl’, lH, dd, J= 
8.8 and 5.9 Hz), 4.36 (H3’, lH, bs), 3.97 (H4$lH, bs), 3.78 (MeO- 
DMT, 6H, s), 3.65 (H5’, lH, m), 3.30 (H5’, lH, m), 1.9 (H2’a, lH, m), 
1.82 (H7, 3H, d, J= 1.2 Hz), 1.7 (H2’P, 1 H, m). FAB-MS (m-NBA): m/z 
545 (M+H+). 
5’O-(9-F/uorenylmethoxycarbony/)thymidine (2). This compound was 
synthesized from fluorenylmethoxycarbonyl chloride (13 mmol, 3.36 g) 
and thymidine (10 mmol, 2.42 g) in pyridine as solvent. The protocol 
used was that reported by Lehmann et a/. [20], making minor changes 
to improve it. For example, the reaction was performed at room temper- 
ature instead of 0°C with no practical difference between product dis- 
tribution. In both cases, the reactions seemed to proceed 
simultaneously, so we allowed 5 min for the compounds to react. 
Although the product was purified by column chromatography, those 
fractions (recovered with acetone) that were contaminated with its 3’ 
counterpart were treated with a small amount of n-hexane to selectively 
obtain the precipitation of compound 2 as a white powder (3.1 g). 
Yield: 66.70/o; R, 0.6; mp 190-191°C; ‘H NMR (CDCI,/DMSO): 6 
10.24 (H3, 1 H, s), 7.76-7.31 (Fmoc-aromatics, 8H), 7.34 (H6, 1 H, q, 
J= 1.0 Hz), 6. 36 (Hl’, lH, t, J= 6.5 Hz), 5.03 (OH 3’, lH, d, J= 4.5 
Hz), 4.53 and 4.45 (CH, of Fmoc, 2H, 2dd, J= 10.5 and 7.0 Hz), 4.44 
and 4.39 (H5’, 2H, 2dd, J= 12.0, 11.5, 5.0 and 3.0 Hz), 4.36 (H3’, 1 H, 
m), 4.25 (CH of Fmoc, 1 H, t, J= 7 Hz), 4.12 (H4’, 1 H, dd, J= 4.0 and 
3.0 Hz), 2.36 (H2’6, 1 H, ddd, J= 14.0, 6.5 and 4.0 Hz), 2.08 (H2’a, 
lH, ddd, J= 13.5, 6.5 and 6.5 Hz), 1.80 (H7, 3H, d, J= 1.0 Hz). FAB- 
MS (m-NBA): m/z 465 (M+H+). 
5~0-(9-Fluorenylmethoxycarbonyl)thym~d~ne-3~yl~o-chloropheny~phos- 
phate-5’-yithymidine (3). Compound 2 (5 mmol, 2.32 g, previously co- 
evaporated with anhydrous pyridine) was activated with 60 ml of a 0.1 M 
solution of the phosphorylating reagent o-chlorophenylphosphoroditria- 
zolide. After 2 h of reaction, when the TLC analysis showed that activa- 
tion was complete, the reaction mixture was transferred, using a plastic 
canule, to another flask containing compound 1 (4.62 mmol, 2.5 g, previ- 
ously dried as above), and dry, double-distilled N-methylimidazole (NMI, 
1.24 ml) was added to catalyze this coupling reaction. When the reaction 
was complete, 2 ml of a 10% aqueous solution in pyridine was added to 
quench the excess of activated nucleoside and was worked up as com- 
pound 1, The fully protected dimer was then subjected to detritylation at 
0°C with 80 ml of 5% dichloroacetic acid in dichloromethane for 5 min, 
after which the solution was quickly neutralized with saturated NaHCO,, 
followed by brine. After drying over anhydrous Na,SO,, filtration and con- 
centration of the organic phase, the remaining yellowish oil was purified 
by flash column chromatography, employing a methanol gradient in 
CHzCI,. Compound 3 eluted with 3% methanol and was obtained as a 
white powder (2.76 g) by precipitation in cold n-hexane. 
Yield: 63%; R, 0.40; mp 120-l 21 “C; ‘H NMR (CDCIsIDMSO) of the 
diastereomeric mixture: F 1 1.30-l 1 .14 (H3, 2H, 4s), 7.87-7.22 (Fmoc- 
aromatics + o-chlorophenyl-aromatics + H6, 14H, m), 6.20 (Hl’, 2H, q, 
J = 6.9 Hz), 5.43 (OH 3’, 1 H, d, J = 4.5 Hz), 5.17 (H3’, 1 H, bs), 4.42- 
4.26 (4H5’ + 1 H4’ + 1 H3’ + CH and CH, of Fmoc, m, 9H), 4.0 (H4’, 
lH, bs), 2.45 (H2’, 2H, m), 2.13 (H2’, 2H, m), 1.71 (H7, 3H, s), 1.70 
(H7,3H, s); 31P NMR (CDCI,/DMSO): 8 -11.13 (s); FAB-MS (m-NBA): 
m/z 879 (M+H+). 
5~0-(9-Fluorenylmetho~carbony/)thym~d~ne-3~y~(o-chloropheny~phos- 
phated’-ylthymidine-3’-yl(o-chlorophenyl)phosphate-5’-ylthymidine (4). 
This compound was synthesized using the protocol described for com- 
pound 3 but at a 3 mmol scale. Compound 3 was first activated with o- 
chlorophenyl-phosphoroditriazolide and then reacted with compound 1. 
The fully protected trimer was subsequently detritylated. Compound 4 
was obtained as a white powder after purification and precipitation. 
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Yield: 67.8%; R, 0.36; mp 128-l 30°C; ‘H NMR (CDCI,/DMSO) of 
the diastereomeric mixture: 6 11.29 (H3, 2H, bs), 1 1.22 (H3, 1 H, bs), 
7.86-7.21 (Fmoc-aromatics + o-chlorophenyl-aromatics + H6, 1 SH), 
6.19 (Hl’, 3H, 2d, J= 6.9 and 6.0 Hz), 5.42 (OH 3’, lH, d, J=4.2 Hz), 
5.22 (H3’, lH, bs), 5.16 (H3’, lH, bs), 4.54-4.28 (CH and CH, of 
Fmoc + 6H5’ + 2H4’ + 1 H3’, 12H, m), 3.99 (H4’, 1 H, bs), 2.47 (H2’, 
4H, m), 2.132 (H2’, 2H, m), 1.70 (H7, 9H, s). 31P NMR 
(CDCI,/DMSO): 6 -11.089 (lP, s), -11.270 (1 P, 2s). FAB-MS 
(m-NBA): m/z 1299 (M+H+). 
5’-0-(9-Fluorenylmefhoxycarbonyl)thymidine-3’-yl(o-chloropheny~-phos- 
phafe-5~ylfhymidine-3’-yl(o-chlorophenyl)-phosphafe-5~ylfhymidine-3’ 
O-methyl-N, N-diisopropylphosphoramidife (5). The Fmoc-trimer 4 
(1 mmol, 1292 mg) was dried by coevaporation with anhydrous pyridine 
(2 x 20 ml), followed by coevaporation with anhydrous THF (20 ml) until 
formation of a white foam, which was redissolved in 20ml of THF, fol- 
lowed by syringe addition of N,N-diisopropylethylamine (DIPEA, 4 mmol, 
696 j.rl) and N,N-diisopropyl-methylphosphonamidic chloride (3 mmol, 
603 j.rl). After 20 min magnetic stirring, the reaction was quenched with 
saturated NaHCO, (5 ml), diluted with CH,CI, and subjected to stan- 
dard work up. The remaining oil was diluted with CH,CI, (5 ml) and puri- 
fied by flash column chromatography with 10% of pyridine in 
dichloromethane. The fractions that contained the compound were 
joined, concentrated and precipitated at -40°C in n-hexane with strong 
stirring. After drying overnight, over phosphorus pentoxide under a high 
vacuum, the Fmoc-trimer-phosphoramidite 5 was obtained as a white 
powder, which was stable at -20°C for at least 2 years. 
Yield: 50.4Vo; R, 0.580; 1 H NMR (CDCI,/DMSO) of the diastereomeric 
mixture: 6 (Fmoc-aromatics + o-chlorophenyl-aromatics + H6, 19H), 6.24 
(Hi’, 3H, m), 5.24 (2H3’, m), 4.60-4.18 (1 H3’+ CH and CH, of Fmoc + 
6H5’ + 3H4’, 13H, m), 3.62-3.45 (CH of isopropyl, 2H, m), 3.37 and 
3.36 (CHsOP, 3H, 2d, J= 13.2 Hz), 2.65-2.17 (H2’, 6H, m), 1.88-1.72 
(H7, 9H, m), 1.241 (CH, of isopropyl, 12H, d, J = 3.3 Hz); 31P NMR 
(CDCI,/DMSO): S 146.40 and 146.90 (1 P), -11 .lO (2P). 
5’-0-(9-Fluorenylmefhoxycarbonyl)-2N-isobufyryldeoxyguanosine 
(Fmoc-dG). This compound was synthesized as compound 2, employ- 
ing 2N-isobutyryldeoxyguanosine (10 mmol, 3.37 g) and Fmoc-Cl 
(13 mmol, 3.36 g) in pyridine as solvent. After normal work up and 
column chromatography purification, we obtained 7.83 g of a white 
powder corresponding to pure Fmoc-dG. This compound was eluted 
with 9% MeOH in CH,CI,. 
Yield: 70.0%; R, 0.35; mp 118-l 2O’C; ‘H NMR (CDCI,): 6 12.41 (Hl, 
1 H, s), 10.57 (NH of dG, 1 H, s), 7.93 (H8, 1 H, s), 7.68-7.13 (Fmoc-aro- 
matics, 8H), 6.18 (Hl’, 1 H, t, J = 6.0 Hz), 5.47 (OH 3, 1 H, bs), 4.80 (H3’, 
1 H, s), 4.49 (CH, of Fmoc + 2H5’ + H4’, 5H, m), 4.14 (CH of Fmoc, 1 H, 
t, J = 7.2 Hz), 2.85 (CH of isobutyryl, 1 H, sept, J = 6.6 Hz), 2.64 (H2’P, 
1 H, bs), 2.46 (H2’P, 1 H, bs), 1.20 (CH, of isobutyryl, 6H, d, J= 6.6 Hz). 
5’-0-(~-Fluorenylmefhoxycarbony~-2N-isobu~ryldeoxyguanosine-3’-yl 
(o-chlorophenyl)-phosphafe-5’-yl-4N-benzoyldeoxycyfidine (Fmoc-GC 
dimer). This compound was prepared as dimer 3, using Fmoc-dG 
(5 mmol, 2.80 g) and three molar equivalents of 4N-benzoyldeoxycytidine 
(15 mmol, 4.97 g) instead of compound 1 and 2. The main difference 
with respect to the procedure of dimer 3, was the absence of the acid 
step no longer necessary to remove a DMT group. After normal work-up, 
column chromatography purification and cold n-hexane precipitation, we 
obtained 2.8 g of a white powder corresponding to the Fmoc-GC dimer. 
The title compound was eluted with 7% MeOH in CH,CI,. 
Yield: 56%; Rr 0.38; mp 128-l 3O’C; 1 H NMR (CDCI,) of the diastere- 
omeric mixture: 6 12.03 and 11.98 (Hl of dG, lH, 2s) 10.78 and 
10.34 (NH of dG, 1 H, 2s), 8.92 (NH of dC, 1 H, bs), 8.39 and 8.19 (H6 
of dC, 1 H, 2d, J = 7 Hz), 7.85-7.40 (Fmoc-aromatics + o-chlorophenyl- 
aromatics + benzoyl-aromatics + HE of dG + H5 of dC, 19H, m), 6.24, 
6.06 and 5.87 (Hl’, 2H, 3m), 5.42 and 5.37 (H3’ of dG, lH, 2m), 4.72 
(H3’ of dC, 1 H, m), 4.63 (H5’ of dC, 2H, m), 4.49-4.20 (CH, of Fmoc + 
H4’ of dG + H4’ of dC + 2H5’ of dG + H3’ of dC, 7H, m), 4.17 (CH of 
Fmoc, 1 H, t, J = 7.5 Hz), 2.98-2.92 (CH of isobutyryl, 1 H, m) 2.91-2.63 
(2H2’ of dG + 2H2’ of dC, 4H, m), 1.26, 1.23 and 1.20 (CH, of isobu- 
tyryl, 6H, 3d, J = 7 Hz). 31P NMR (CDCI,): 6 -8.39 and -8.20 (2s). 
5’-0-(9-Fluorenylmefhoxycarbonyl)-2N-isobufyryldeoxyguanosine-3~- 
yl(o-chlorophenyl)-phosphate-5’-yl-4N-benzoyldeoxycytidine-3’-yl(o- 
chlorophenyl)phosphate-5’-ylthymidine (Fmoc-GCT trimer). This 
compound was synthesized by the procedure described for the Fmoc- 
GC dimer, using as starting materials the Fmoc-GC dimer (3 mmol, 
3.18 g) and thymidine (9 mmol, 2.18 g). After normal work-up, column 
chromatography purification and cold n-hexane precipitation, we 
obtained 2.21 g of a white powder corresponding to the Fmoc-GCT 
trimer. The title compound was eluted with 8% MeOH in CH,CI,. 
Yield: 53%; R, 0.36; mp 133-135°C; ‘H NMR (CDCI,) of the diastere- 
omeric mixture: 6 12.14 (Hl of dG, 1 H, s), 10.43, 10.30 and 10.23 (NH 
of dG, 1 H, 3s), 9.81, 9.68 and 9.58 (H3 of dT, 1 H, 3bs), 8.58 and 8.07 
(H6 of dC, 1 H, 2m), 7.98 (H8 of dG, 1 H, m), 7.92-7.04 (aromatics, 24H, 
m), 6.20 (Hl’, 3H, m), 5.41 (H3’ of dG, 1 H, m), 5.33 (H3’ of dC, 1 H, m), 
4.63-4.25 (CH, of Fmoc + H4’ and H5’ of dG + H4’ and H5’ of dC + 
H3’,H4’ and H5’ of dT, 12H, m), 4.17 (CH of Fmoc, 1 H, t, J = 7Hz), 3.00- 
2.15 (2H2’ of dG + 2H2’ of dC + 2H2’ of dT + CH of isobutyryl, 7H, m), 
1.79 (H7 of dT, 3H, m), 1.17 (CH, of isobutyryl, 6H, m); 31P NMR 
(CDCI,): 6 -6.90, -6.98, -7.07, -7.12, -7.16, -7.48, -7.58, -7.74 (8s). 
5’-0-(9-Fluorenylmethoxycarbonyl)-2N-isobu~ryldeoxyguanosine-3’~l 
(o-chlorophenyl)-phosphate-5’-yl-4N-benzoyldeoxycytidine-3’-yl(o- 
chlorophenyl)phosphate-5’-ylthymidine-3’-O-mefhyl-N,N-diisopropyl- 
phosphoramidite (Fmoc-GCT-phosphoramidite). Phosphitylation of 
the Fmoc-GCT trimer (1 mmol, 1.47 g) was performed using the proce- 
dure described for preparation of compound 5. In this case, however, 
the Fmoc-GCT-phosphoramidite was purified over silica gel 60 
(40-63um) instead of silica gel 60H, obtaining a product in high 
purity. The compound was eluted with 20% pyridine in CH,CI, and 
precipitated over cold n-hexane to obtain 671 mg of a white powder 
that was ready dissolved in acetonitrile. 
Yield: 41%; IH NMR (CDCI,): 6 12.10 (Hl of dG, 1 H, Is), 10.68, 
10.65, 10.62 and 10.29 (NH of dG, lH, 3s), 8.89 (H3 of dT, lH, bs), 
8.22-8.06 (H6 of dC, lH, m), 7.83-7.10 (aromatics, 20 H, m), 6.39- 
5.89 (Hl’, 3H, m), 5.40-5.31 (H3’ of dG + H3’ of dC, 2H, m), 4.66- 
4.32 (CH, of Fmoc + H4’ of dG + H4’ and H5’ of dC + H3’, H4’ and 
H5’ of dT, 1 OH, m), 4.22 (CH of Fmoc + H5’ of dG, 3H, m), 3.56 (CH 
of isopropyl, 2H, m), 3.36 (MeOP, 3H, m), 3.1 O-2.1 0 (CH of isobutyryl 
+ H2’ of dG + H2’ of dC + H2’ of dT, 7H, m), 1.83 (H7 of dT, 3H, m), 
1.26 (CH3 of isopropyl, 12H, m), 1 .16 (CH, of isobutyryl, 6H, m); 31P 
NMR (CDCI,): 6 150.60-l 49.97 (P of phosphoramidite, 1 P, m), -6.62 
to -7.44 (P of phosphates, 2P, m). 
5~0-(9-Fluorenylmethoxycarbonyl)-2N-isobutyryldeoxyguanosine-3~0- 
methyl-N,N-diisopropylphosphoramidife (Fmoc-dG-phosphoramidite). 
This compound was synthesized and purified by the procedure 
described by Balgobin et al. [19]. After precipitation over cold n-hexane, 
a white powder corresponding to the title compound was obtained and 
dried overnight over phosphorus pentoxide under high vacuum. 
‘H NMR (CDCI,) of the diastereomeric mixture: 6 11.9 (Hl, lH, bs), 
8.96 (NH of dG, 1 H, bs), 7.79 and 7.78 (H8, 1 H, 2s), 7.76-7.22 (Fmoc- 
aromatics, 8H, m), 6.25 (Hl’, lH, dd, J= 7.5 and 6.0 Hz), 4.66 
(H3’+1 H5’, 2H, m), 4.48 (CH, of Fmoc, 2H, m), 4.43-4.38 (1 H5’ + H4’, 
2H, m), 4.26 and 4.25 (CH of Fmoc, lH, 2t, J= 7.5 Hz), 3.60 (CH of 
isopropyl, 2H, m), 3.4 (MeOP, 3H, 2d, J = 13.5 Hz), 2.8 (CH of isobu- 
tyryl, 1 H, m), 2.59 (H2’, 2H, m), 1.22-i .16 (CH, of isopropyl + CH, of 
isobutyryl, 18H, m). 31P NMR (CDCI,): 6 150.04 and 149.77 (2s). 
5’-0-Levulinyl-2N-isobutyryldeoxyguanosine~3’-O-methyl-N,N-diisopro- 
pylphosphoramidife (Lev-dG-phosphoramidite). 5’-O-Lev-2isobutyryl- 
deoxyguanosine (1 mmol, 435 mg, synthesized with the procedure 
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reported by van Boom et al. [24]) was phosphitylated under the condi- 
tions used for compound 5, to afford a white foam after purification. 
1 H NMR (CDCI,) of the diastereomeric mixture: 6 11.96 (Hl , 1 H, bs), 
9.1 (NH of dG, lH, bs), 7.78 and 7.77, (HE, lH, 2s), 6.21 and 6.20 
(Hl’, 1 H, 2t, J = 7.0 Hz), 4.58 (H3’ + 1 H5’, 2H, m), 4.36 (1 H.5’ + H4’, 
2H, m), 3.59 (CH of isopropyl, 2H, m), 3.40 and 3.39 (CHsOP, 3H, 2d, 
J = 13.5 Hz), 2.83 (CH of isobutyryl, 1 H, m), 2.72 (CH,-COP + HP’o, 
3H, m), 2.57 (CH,COMe + H2’6, 3H, m), 2.15 and 2.14 (CH, of lev- 
ulinyl, 3H, 2s) 1.49 and 1.48 (CH, of isobutyryl, 6H, 2d, J= 7.0 Hz), 
1.18 (CH, of isopropyl, 12H, d, J =7.0 Hz). 31P NMR (CDCI,): 6 
149.92 and 149.62 (2s). 
Synthesis of oligonucleotide libraries 
For the experiments with the Fmoc-TTT-phosphoramidite, two oligonu- 
cleotide libraries with the sequence: 5’ CC GGA ATT CGA GCT CGX 
TAC CCX GGG ATC CTC CTA GC 3’ were synthesized by the phos- 
phite-triester method, employing a combination of DMT-nucleoside-Me- 
phosphoramidites (for assembling of the wild-type sequence) and the 
Fmoc-trimer-phosphoramidite 5. Here X represents mixtures with differ- 
ent proportions of DMT-dGib-phosphoramidite and the Fmoc-trimer- 
phosphoramidite 5. In the library at low mutagenesis rate (LMRL), X 
corresponded to an acetonitrile/THF (3:l v/v) solution being 0.087M in 
DMT-dGib-phosphoramidite and 0.011 M in Fmoc-trimer-phospho- 
ramidite 5 (rate 7.9:1 .O). In the case of the library at high mutagenesis 
rate (HMRL), X was 0.075 M in DMT-dGib-phosphoramidite and 
0.055 M in Fmoc-trimer-phosphoramidite 5 (rate 1.36:1 .O). The coupling 
efficiency of the trimer was calculated by the difference between the 
DMT cation released in the 14th and 15th coupling and the 20th and 
21 st coupling. Measuring the absorbance at 304 nm of the Fmoc group 
released with 5% piperidine in acetonitrile gave a very similar result. 
The synthesis of the mutagenic oligonucleotides required the use of 
the fifth vial of the synthesizer for the X mixture and to program the syn- 
thesis in three steps: 
fragment 1: 5’ CCX GGG ATC CTC CTA GC 3’ 
fragment 2: 5’ CGX TAC 3’ fragment 1 
fragment 3: 5’ CC GGA All CGA GCT 3’ fragment 2 
The synthesis cycles for the first two fragments were programmed Tr-on 
and that of the third fragment was Tr-off. As soon as the synthesis of 
fragment 1 concluded, it was subjected, in the same column, to a 1 min 
manual treatment with 3 ml of a 5% piperidine solution in acetonitrile to 
remove the Fmoc group. After washing with acetonitrile, the column was 
reconnected to the on-line tubing and fragment 2 was synthesized. The 
process for removal of the Fmoc group was repeated and the synthesis 
of the fragment 3 was finally performed to generate the fully protected 
oligonucleotide library. The oligonucleotides were de-methylated with 
thiophenol/TEA/dioxane, followed by a treatment with 0.4 M P-pyridineal- 
doxime and 0.4 M 1 ,1,3,3+etramethylguanidinium in dioxane/water (1 :l 
v/v) and 28% NH,OH.The oligonucleotides were purified by elec- 
trophoresis in 15% polyacrilamide gels containing 8 M urea. 
A third oligonucleotide (extension primer 1, EPl) with the sequence 
5’GCT AGG AGG ATC C3’ was synthesized to prime the mutagenic 
oligonucleotides in order to construct the mutagenic cassettes with the 
aid of Klenow polymerase. 
The alanine-scanning experiments were performed with the Fmoc- 
GCT-phosphoramidite. In this case, as above, we also synthesized two 
oligonucleotide libraries with different levels of substoichiometric cou- 
pling of the trinucleotide, now with the sequence: 
5’ TAG GAG GAT CCC CGG GTAX CCGX AGCX TCG AAT TCA 
CTC GGA C 3’ 
where X represented the coupling of diluted solutions of the Fmoc- 
GCT-phosphoramidite (16.7 mM and 31 .l mM acetonitrile solutions for 
libraries LM-AS and HM-AS respectively). This trimer was placed in vial 
X of the synthesizer and coupled through a modified cycle of synthesis 
lacking the capping step to allow all hydroxyl groups that did not react 
with the trimer to react in the next cycle with the DMT-nucleoside-Me- 
phospkoramidite that comprised the first nucleotide of the wild-type 
codon. After three monomer couplings, the Fmoc was removed as 
above and the synthesis was completed. 
Finally, a second extension primer (EP2) with the sequence 5’GCT 
CGA GTG AAT TCG 3’ was synthesized to generate the alanine-scan- 
ning cassettes. 
Recombinant DNA methods 
Following established recombinant DNA methods [251 we processed 
and cloned synthetic DNA to generate mutant libraries. 50 pmol of each 
gel-purified oligo (HMRLILMRL with EPl or LM-AS/HM-AS with EP2) 
were annealed by incubating for a few minutes at 95°C and allowing to 
cool down to 37°C. Full duplex molecules were obtained by the action 
of Klenow fragment DNA polymerase I. The duplex DNA products were 
gel-purified after digestion with EcoRl and BarnHI and ligated to plasmid 
pUC19 [26] previously digested with the same enzymes. The ligation 
mixture was electroporated into E. co/i JMl 01 [26] and the transformed 
cells plated in selective media containing ampicillin and incubated 
overnight. 40 clones for each of the HMRL and LMRL libraries, and 50 
clones for each of the LM-AS and HM-AS libraries were picked at 
random for each of the four mutagenic regimes, cultured in liquid 
medium and plasmid DNA isolated by mini-preps [25] to perform restric- 
tion analysis with enzymes Sacl and Smal, in the case of HMRL and 
LMRL. The nucleotide sequence of the relevant DNA segment was 
obtained for 16 colonies (four for each restriction digestion outcome: no 
Sacl or Smal site present, Sacl but no Smal, Smal but no Sacl, both 
sites present), utilizing Thermosequenase according to the manufac- 
turer’s procedure (Amersham). In the case of LM-AS and HM-AS, 
clones picked at random were analyzed directly by DNA sequencing 1 H 
and s1P NMR spectrums of Fmoc-GCT-phosphoramidite. 
Supplementary material 
Supplementary material available with the online version of this paper 
includes the 1H and 31P NMR spectra of Fmoc-GCT-phosphoramidite. 
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